These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 33967773)

  • 81. Vitamin D and COVID-19: Role of ACE2, age, gender, and ethnicity.
    Getachew B; Tizabi Y
    J Med Virol; 2021 Sep; 93(9):5285-5294. PubMed ID: 33990955
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The role of sex and inflammation in cardiovascular outcomes and mortality in COVID-19.
    Minhas AS; Shade JK; Cho SM; Michos ED; Metkus T; Gilotra NA; Sharma G; Trayanova N; Hays AG
    Int J Cardiol; 2021 Aug; 337():127-131. PubMed ID: 33974962
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients.
    Schneider J; Jaenigen B; Wagner D; Rieg S; Hornuss D; Biever PM; Kern WV; Walz G
    PLoS One; 2021; 16(5):e0249760. PubMed ID: 33974624
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
    RECOVERY Collaborative Group
    Lancet; 2021 May; 397(10289):2049-2059. PubMed ID: 34000257
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Remdesivir for coronavirus disease 2019 (COVID-19): a systematic review with meta-analysis and trial sequential analysis of randomized controlled trials.
    Okoli GN; Rabbani R; Copstein L; Al-Juboori A; Askin N; Abou-Setta AM
    Infect Dis (Lond); 2021 Sep; 53(9):691-699. PubMed ID: 33974479
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Assessment of the Association of Vitamin D Level With SARS-CoV-2 Seropositivity Among Working-Age Adults.
    Li Y; Tong CH; Bare LA; Devlin JJ
    JAMA Netw Open; 2021 May; 4(5):e2111634. PubMed ID: 34009346
    [TBL] [Abstract][Full Text] [Related]  

  • 87. BNT162b2 Messenger RNA Vaccination Did Not Prevent an Outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 Variant 501Y.V2 in an Elderly Nursing Home but Reduced Transmission and Disease Severity.
    Bailly B; Guilpain L; Bouiller K; Chirouze C; N'Debi M; Soulier A; Demontant V; Pawlotsky JM; Rodriguez C; Fourati S
    Clin Infect Dis; 2022 Feb; 74(3):517-520. PubMed ID: 33993228
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives.
    Al-Kuraishy HM; Al-Gareeb AI; Alqarni M; Cruz-Martins N; El-Saber Batiha G
    Front Pharmacol; 2021; 12():642822. PubMed ID: 33967777
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2.
    Azouz NP; Klingler AM; Callahan V; Akhrymuk IV; Elez K; Raich L; Henry BM; Benoit JL; Benoit SW; Noé F; Kehn-Hall K; Rothenberg ME
    Pathog Immun; 2021; 6(1):55-74. PubMed ID: 33969249
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients.
    Wendt R; Thijs L; Kalbitz S; Mischak H; Siwy J; Raad J; Metzger J; Neuhaus B; Leyen HV; Dudoignon E; Mebazaa A; Spasovski G; Milenkova M; Canevska-Talevska A; Czerwieńska B; Wiecek A; Peters B; Nilsson Å; Schwab M; Rothfuss K; Lübbert C; Staessen JA; Beige J;
    EClinicalMedicine; 2021 Jun; 36():100883. PubMed ID: 33969282
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2.
    Abraham EH; Guidotti G; Rapaport E; Bower D; Brown J; Griffin RJ; Donnelly A; Waitzkin ED; Qamar K; Thompson MA; Ethirajan S; Robinson K
    Purinergic Signal; 2021 Sep; 17(3):399-410. PubMed ID: 33970408
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Efficacy and safety of short-wave diathermy treatment for moderate COVID-19 patients: a prospective, double-blind, randomized controlled clinical study.
    Tian F; Wang J; Xi X; Sun X; He M; Zhao C; Feng F; Wang H; Sun W; Mao L; Hu X; Yuan H
    Eur J Phys Rehabil Med; 2022 Feb; 58(1):137-143. PubMed ID: 34042412
    [TBL] [Abstract][Full Text] [Related]  

  • 93.
    Schönfelder K; Breuckmann K; Elsner C; Dittmer U; Fistera D; Herbstreit F; Risse J; Schmidt K; Sutharsan S; Taube C; Jöckel KH; Siffert W; Kribben A; Möhlendick B
    Front Genet; 2021; 12():667231. PubMed ID: 33968142
    [TBL] [Abstract][Full Text] [Related]  

  • 94. High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019.
    Xia G; Fan D; He Y; Zhu Y; Zheng Q
    Nutrition; 2021; 91-92():111405. PubMed ID: 34388587
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Use of the Anticoagulant Heparin and Corticosteroid Dexamethasone as Prominent Treatments for COVID-19.
    Braz-de-Melo HA; Faria SS; Pasquarelli-do-Nascimento G; Santos IO; Kobinger GP; Magalhães KG
    Front Med (Lausanne); 2021; 8():615333. PubMed ID: 33968948
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Paradoxical relationship between proton pump inhibitors and COVID-19: A systematic review and meta-analysis.
    Zippi M; Fiorino S; Budriesi R; Micucci M; Corazza I; Pica R; de Biase D; Gallo CG; Hong W
    World J Clin Cases; 2021 Apr; 9(12):2763-2777. PubMed ID: 33969059
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface.
    Lu-Culligan A; Chavan AR; Vijayakumar P; Irshaid L; Courchaine EM; Milano KM; Tang Z; Pope SD; Song E; Vogels CBF; Lu-Culligan WJ; Campbell KH; Casanovas-Massana A; Bermejo S; Toothaker JM; Lee HJ; Liu F; Schulz W; Fournier J; Muenker MC; Moore AJ; ; Konnikova L; Neugebauer KM; Ring A; Grubaugh ND; Ko AI; Morotti R; Guller S; Kliman HJ; Iwasaki A; Farhadian SF
    Med; 2021 May; 2(5):591-610.e10. PubMed ID: 33969332
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.
    Augustin M; Schommers P; Stecher M; Dewald F; Gieselmann L; Gruell H; Horn C; Vanshylla K; Cristanziano VD; Osebold L; Roventa M; Riaz T; Tschernoster N; Altmueller J; Rose L; Salomon S; Priesner V; Luers JC; Albus C; Rosenkranz S; Gathof B; Fätkenheuer G; Hallek M; Klein F; Suárez I; Lehmann C
    Lancet Reg Health Eur; 2021 Jul; 6():100122. PubMed ID: 34027514
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.
    Clark CC; Jukema BN; Barendrecht AD; Spanjaard JS; Jorritsma NKN; Smits S; de Maat S; Seinen CW; Verhoef S; Parr NMJ; Sebastian SAE; Koekman AC; van Wesel ACW; van Goor HMR; Spijkerman R; Bongers SH; van der Vries E; Nierkens S; Boes M; Koenderman L; Kaasjager KAH; Maas C
    Front Med (Lausanne); 2021; 8():650129. PubMed ID: 33968958
    [No Abstract]   [Full Text] [Related]  

  • 100. Correction to: Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial.
    Ranjbar K; Moghadami M; Mirahmadizadeh A; Fallahi MJ; Khaloo V; Shahriarirad R; Erfani A; Khodamoradi Z; Saadi MHG
    BMC Infect Dis; 2021 May; 21(1):436. PubMed ID: 33975548
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.